The Chemours Company (NYSE:CC) Holdings Lifted by Landscape Capital Management L.L.C.

Landscape Capital Management L.L.C. boosted its holdings in The Chemours Company (NYSE:CC) by 243.6% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 35,032 shares of the specialty chemicals company’s stock after acquiring an additional 24,837 shares during the quarter. Landscape Capital Management L.L.C.’s holdings in Chemours were worth $592,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. GAMMA Investing LLC lifted its position in shares of Chemours by 99.7% during the 4th quarter. GAMMA Investing LLC now owns 1,532 shares of the specialty chemicals company’s stock valued at $26,000 after acquiring an additional 765 shares during the last quarter. KBC Group NV raised its position in shares of Chemours by 38.2% during the fourth quarter. KBC Group NV now owns 6,176 shares of the specialty chemicals company’s stock worth $104,000 after purchasing an additional 1,708 shares during the period. EMC Capital Management boosted its position in shares of Chemours by 74.6% in the 4th quarter. EMC Capital Management now owns 9,534 shares of the specialty chemicals company’s stock valued at $161,000 after purchasing an additional 4,073 shares during the period. Matrix Trust Co increased its stake in Chemours by 715.7% in the 4th quarter. Matrix Trust Co now owns 9,952 shares of the specialty chemicals company’s stock worth $168,000 after purchasing an additional 8,732 shares in the last quarter. Finally, Larson Financial Group LLC purchased a new position in shares of Chemours in the fourth quarter worth approximately $205,000. 76.26% of the stock is currently owned by institutional investors.

Chemours Stock Down 7.1 %

Chemours stock opened at $10.61 on Monday. The Chemours Company has a 1-year low of $10.12 and a 1-year high of $29.21. The firm’s fifty day simple moving average is $15.67 and its 200-day simple moving average is $18.01. The company has a current ratio of 1.68, a quick ratio of 0.92 and a debt-to-equity ratio of 6.70. The company has a market capitalization of $1.58 billion, a P/E ratio of 18.61 and a beta of 1.84.

Chemours (NYSE:CC) last posted its earnings results on Tuesday, February 18th. The specialty chemicals company reported $0.11 earnings per share for the quarter, topping the consensus estimate of $0.10 by $0.01. Chemours had a return on equity of 26.54% and a net margin of 1.51%. The firm had revenue of $1.36 billion during the quarter, compared to analyst estimates of $1.37 billion. Sell-side analysts forecast that The Chemours Company will post 2.03 earnings per share for the current fiscal year.

Chemours Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, March 14th. Investors of record on Friday, February 28th were paid a $0.25 dividend. The ex-dividend date was Friday, February 28th. This represents a $1.00 dividend on an annualized basis and a yield of 9.43%. Chemours’s payout ratio is presently 175.44%.

Analysts Set New Price Targets

Several analysts have recently commented on the company. BMO Capital Markets decreased their target price on Chemours from $34.00 to $27.00 and set an “outperform” rating for the company in a research report on Wednesday, February 19th. Truist Financial began coverage on Chemours in a research report on Tuesday, January 28th. They set a “buy” rating and a $27.00 price objective for the company. Morgan Stanley dropped their target price on Chemours from $25.00 to $22.00 and set an “equal weight” rating on the stock in a report on Monday, January 13th. Mizuho upgraded shares of Chemours from a “neutral” rating to an “outperform” rating and set a $19.00 price target for the company in a report on Thursday, March 27th. Finally, Barclays dropped their price objective on shares of Chemours from $19.00 to $16.00 and set an “equal weight” rating on the stock in a research note on Tuesday, April 1st. Four analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. According to MarketBeat, Chemours has an average rating of “Moderate Buy” and an average price target of $22.56.

About Chemours

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.